EUVIMEDEUVIMED entdecken
Crossref

Lung cancer statistics, 2023

Tyler B Kratzer iD, Priti Bandi, Neal D Freedman, Robert A Smith iD, William D Travis, Ahmedin Jemal iD, Rebecca L Siegel

Cancer · 15.04.2024 · 130 (8) · 1330-1348

DOI: 10.1002/cncr.35128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, online erschienen am 27.01.2024. Verfasst von Tyler B Kratzer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Surveillance and Health Equity Science, American Cancer Society, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Lung Neoplasms, Neoplasms. Die Arbeit wurde bisher 501-mal zitiert (Crossref) und nennt 191 Literaturangaben. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite decades of declining mortality rates, lung cancer remains the leading cause of cancer death in the United States. This article examines lung cancer incidence, stage at diagnosis, survival, and mortality using population‐based data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries. Over the past 5 years, declines in lung cancer mortality became considerably greater than declines in incidence among men (5.0% vs. 2.6% annually) and women (4.3% vs. 1.1% annually), reflecting absolute gains in 2‐year relative survival of 1.4% annually. Improved outcomes likely reflect advances in treatment, increased access to care through the Patient Protection and Affordable Care Act, and earlier stage diagnosis; for example, compared with a 4.6% annual decrease for distant‐stage disease incidence during 2013–2019, the rate for localized‐stage disease rose by 3.6% annually. Localized disease incidence increased more steeply in states with the highest lung cancer screening prevalence (by 3%–5% annually) than in those with the lowest (by 1%–2% annually). Despite progress, disparities remain. For example, Native Americans have the highest incidence and the slowest decline (less than 1% annually among men and stagnant rates among women) of any group. In addition, mortality rates in Mississippi and Kentucky are two to three times higher than in most western states, largely because of elevated historic smoking prevalence that remains. Racial and geographic inequalities highlight longstanding opportunities for more concerted tobacco‐control efforts targeted at high‐risk populations, including improved access to smoking‐cessation treatments and lung cancer screening, as well as state‐of‐the‐art treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsNeoplasmsMaleHumansFemaleUnited StatesEarly Detection of CancerPatient Protection and Affordable Care ActSEER ProgramRegistriesIncidence

Stichwörter der Autor:innen

cancer screeningcancer statisticscancer surveillancelung cancerstage at diagnosissurvival

Autor:innen und Institutionen

  • Surveillance and Health Equity Science, American Cancer Society, Atlanta, Georgia, USA.
  • Tobacco Control Research Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland, USA.
  • Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.

ORCID-Profile: Tyler B Kratzer, Robert A Smith, Ahmedin Jemal

Förderung

  • NCI NIH HHS

Zitieren

APA

Kratzer, T. B., Bandi, P., Freedman, N. D., Smith, R. A., Travis, W. D., Jemal, A., & Siegel, R. L. (2024). Lung cancer statistics, 2023. Cancer, 130(8), 1330-1348. https://doi.org/10.1002/cncr.35128

Vancouver

Kratzer TB, Bandi P, Freedman ND, Smith RA, Travis WD, Jemal A, et al. Lung cancer statistics, 2023. Cancer. 2024;130(8):1330-1348. doi:10.1002/cncr.35128

BibTeX
@article{Kratzer2024,
  author = {Kratzer, Tyler B and Bandi, Priti and Freedman, Neal D and Smith, Robert A and Travis, William D and Jemal, Ahmedin and Siegel, Rebecca L},
  title = {Lung cancer statistics, 2023},
  journal = {Cancer},
  year = {2024},
  volume = {130},
  number = {8},
  pages = {1330--1348},
  doi = {10.1002/cncr.35128}
}
Kostenlos starten →